Talk:HER2

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): EmJT, Saramcallaster.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 22:54, 16 January 2022 (UTC)

Does HER2 have a ligand?
The following excerpt from the article seems self-contradictory: ''HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. However, ErbB receptors dimerise on ligand binding''. Is HER2 an "adopted orphan" receptor, and if so, what is its ligand? Boghog2 19:03, 4 June 2007 (UTC)


 * I disagree- if the ligand is unknown it is an orphan receptor, and that should be stated (If the ligand is known that should be stated). Receptors of this family (EGFR) dimerize on binding, and presumably HER2 does also, even if it can't be demonstrated for lack of ligand. So the first statement should definitely be kept, second perhaps modify to "receptors of the EGFR family . . ." Eaberry (talk) 22:08, 14 March 2013 (UTC)


 * Heregulin (NRG1) appears to a ligand for HER2 hence HER2 has been deorphanized. In any case, the phrase "orphan receptor" has been removed sometime ago. Boghog (talk) 22:30, 6 January 2014 (UTC)

HER2 testing
How do you test for HER2? Is it a simple blood test?Libraryboy70 (talk) 14:48, 28 October 2009 (UTC)

Image: receptor distribution
Hi, can someone please explain what's the significance of the receptor distribution illustrated on the second image. Otherwise, it makes no sense to have it in the article. Thanks. -Eleassar my talk 15:29, 27 November 2011 (UTC)

Citation
I found a citation stating that 30 % of all breast cancers overexpress HER2/neu, however it is only one study including 189 patients, so I don't think it's statistically significant And another one included 61 patients and found a HER2/neu overexpression in 28 % Pickdu (talk) 21:03, 6 January 2014 (UTC)


 * Thanks for the citations. Per WP:MEDRS, secondary sources are needed to support medical claims, and preferably more recent citations (within the last five years).  Fortunately there was a recent review article already cited in the HER2/neu section that supports the 30% number (see ).  I have also added this citation to the lead. Boghog (talk) 22:45, 6 January 2014 (UTC)

Need more on it being a proto-oncogene
since being a proto-oncogene is behind some of its aliases. What mutations and how does that cause over-activation ? - Rod57 (talk) 12:53, 10 November 2015 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified 2 external links on HER2/neu. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added tag to http://medisapiens.com/ERBB2
 * Added archive https://web.archive.org/web/20080516045758/http://www.aacr.org/home/public--media/for-the-media/fact-sheets/cancer-concepts/her2.aspx to http://www.aacr.org/home/public--media/for-the-media/fact-sheets/cancer-concepts/her2.aspx
 * Added archive https://web.archive.org/web/20081011055216/http://www.her2.co.za/care/ to http://www.her2.co.za/care/

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 06:35, 27 October 2017 (UTC)

The official gene name according to HGNC (genenames.org) is ERBB2
What is the Wikipedia policy on using official gene names as endorsed by the HUGO Gene Nomenclature Committee? --130.60.206.75 (talk) 09:24, 30 December 2019 (UTC)

Diagnostics, cancer biopsy
Is the information here (shown below) correct, it states that " is important that trastuzumab is restricted to HER2-positive". Should that read HER2 negative?

" Diagnostics Cancer biopsy HER2 testing is performed in breast cancer patients to assess prognosis and to determine suitability for trastuzumab therapy. It is important that trastuzumab is restricted to HER2-positive individuals as it is expensive and has been associated with cardiac toxicity. For HER2-positive tumours, the risks of trastuzumab clearly outweigh the benefits." 176.252.111.21 (talk) 04:52, 24 July 2021 (UTC)